Literature DB >> 10367905

Granzyme A initiates an alternative pathway for granule-mediated apoptosis.

S Shresta1, T A Graubert, D A Thomas, S Z Raptis, T J Ley.   

Abstract

Granzyme (gzm) B-deficient cytotoxic lymphocytes (CTL) have a severe defect in the rapid induction of target cell apoptosis that is almost completely corrected by prolonged incubation of the CTL effectors and their targets. We show in this report that perforin-dependent, gzmB-independent cytotoxicity is caused by gzmA (or tightly linked genes). CTL deficient for gzmA and gzmB retain normal perforin function, but these CTL have a cytotoxic defect in vivo that is as severe as perforin-deficient CTL. Collectively, these results suggest that perforin provides target cell access and/or trafficking signals for the gzms, and that the gzms themselves deliver the lethal hits. The gzmA pathway appears to function independently from gzmB and may therefore provide a critical "back-up" system when gzmB is inhibited in the target cell.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10367905     DOI: 10.1016/s1074-7613(00)80059-x

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  37 in total

1.  Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis.

Authors:  D Zhang; P J Beresford; A H Greenberg; J Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

Review 2.  Granzyme A activates another way to die.

Authors:  Judy Lieberman
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

3.  Catalog of 680 variations among eight cytochrome p450 ( CYP) genes, nine esterase genes, and two other genes in the Japanese population.

Authors:  Susumu Saito; Aritoshi Iida; Akihiro Sekine; Saori Kawauchi; Shoko Higuchi; Chie Ogawa; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2003-04-29       Impact factor: 3.172

Review 4.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

5.  A proteomic approach for the discovery of protease substrates.

Authors:  Andrew J Bredemeyer; Renate M Lewis; James P Malone; Alan E Davis; Julia Gross; R Reid Townsend; Timothy J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

Review 6.  A quarter century of granzymes.

Authors:  C L Ewen; K P Kane; R C Bleackley
Journal:  Cell Death Differ       Date:  2011-11-04       Impact factor: 15.828

7.  Granzymes and caspase 3 play important roles in control of gammaherpesvirus latency.

Authors:  Joy Loh; Dori A Thomas; Paula A Revell; Timothy J Ley; Herbert W Virgin
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 8.  Use of protease proteomics to discover granzyme B substrates.

Authors:  Andrew J Bredemeyer; R Reid Townsend; Timothy J Ley
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 9.  Immune regulation of viral infection and vice versa.

Authors:  Herbert W Virgin
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

10.  SERPINB12 Is a Slow-Binding Inhibitor of Granzyme A and Hepsin.

Authors:  Jason Z Niehaus; Mark T Miedel; Misty Good; Allyson N Wyatt; Stephen C Pak; Gary A Silverman; Cliff J Luke
Journal:  Biochemistry       Date:  2015-11-05       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.